Clinical Trials

55 enrolled

Other solid neoplasm

Solid Tumor

NCT04093323 2026-02-25

Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma

1 enrolled

Dermatologic

Melanoma

NCT01356290 2026-02-23

MEMMAT

232 enrolled

CNS

Ependymoma, Medulloblastoma, Recurrence

NCT07174570 2026-01-28

Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer

39 enrolled

Carcinoma, Hepatocellular

NCT03926338 2025-11-20

PICC

270 enrolled

Turcot syndrome, Colorectal Neoplasms

NCT07154316 2025-09-04

Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer

138 enrolled

Colorectal Neoplasms

NCT07150949 2025-09-02

Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC)

138 enrolled

Locally Advanced Rectal Cancer

NCT07104266 2025-08-05

Triple Negative Breast Cancer and Celecoxib. Pilot Study

30 enrolled

Triple Negative Breast Neoplasms

NCT04162873 2025-02-12

Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer

13 enrolled 36 charts

Head & Neck

Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Paranasal Sinus Neoplasms

NCT03084536 2024-12-24

PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery

134 enrolled 9 charts

Breast Neoplasms

NCT02641314 2024-05-10

METRO-NB2012

18 enrolled

CNS

Neuroblastoma

NCT05578287 2023-12-07

DETECT

29 enrolled

Colorectal Neoplasms

NCT00665457 2023-09-13

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

3 enrolled 6 charts

Breast Neoplasms

NCT00846430 2023-08-30

Medical Treatment of "High-Risk" Neurofibromas

9 enrolled 9 charts

CNS

Neurofibroma, Neurofibromatosis 1

NCT00538031 2023-04-21

Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

52 enrolled 10 charts

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT01285817 2023-03-13

SFCE METRO 01

79 enrolled

Survival Without Progression

NCT00503035 2023-02-13

Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers

51 enrolled 10 charts

Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT02748707 2022-04-28

ERLO-XIB

64 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

NCT03403634 2022-03-02

Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver

19 enrolled 15 charts

Colorectal Neoplasms

NCT02484664 2022-01-20

COLA

12 enrolled 11 charts

Lymphangioleiomyomatosis

NCT00112502 2021-10-18

Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme

178 enrolled 23 charts

CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00033371 2020-09-29

Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis

205 enrolled 16 charts

Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT00020878 2020-08-03

Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers

21 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00062179 2020-08-03

Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer

7 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02280694 2020-02-12

LDMchemoCRC

45 enrolled

Colorectal Neoplasms

NCT03896113 2020-01-10

CELEBRIDO

48 enrolled

Gynecologic

Endometrial Neoplasms

NCT03185871 2019-11-15

Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses

Phase 2 Withdrawn

Breast Neoplasms

NCT03864575 2019-07-12

NICE-COMBO

68 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT00061893 2019-02-15

Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors

38 enrolled 10 charts

Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00022399 2019-02-08

Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer

73 enrolled

Genitourinary

Prostatic Neoplasms

NCT00256321 2019-02-08

Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction Carcinoma

4 enrolled

Stomach Neoplasms

NCT00068432 2018-10-31

Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer

28 enrolled

Pancreatic Neoplasms

NCT00080782 2018-10-31

Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases

14 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT00088972 2018-08-10

S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women

8 enrolled 5 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Ductal, Breast

NCT01220973 2018-06-08

Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer

27 enrolled 6 charts

Genitourinary

Prostatic Neoplasms

NCT03498326 2018-05-30

GCRP

480 enrolled

Pancreatic Neoplasms

NCT00052611 2018-03-29

Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia

23 enrolled

Head & Neck

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Salivary Gland Neoplasms

NCT01729923 2018-01-16

ADAPT

27 enrolled 10 charts

Colonic Neoplasms, Rectal Neoplasms

NCT01695226 2018-01-09

Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer

Breast Neoplasms

NCT02615574 2017-09-26

A Study of Type-1 Polarized Dendritic Cell (αDC1) Vaccine in Combination With Tumor-Selective Chemokine Modulation (Interferon-α2b, Rintatolimod, and Celecoxib) in Subjects With Chemo-Refractory Metastatic Colorectal Cancer

Phase 2 Withdrawn

Colorectal Neoplasms

NCT00137852 2017-09-20

Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer

35 enrolled

Esophageal Neoplasms

NCT00081263 2017-09-15

Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia

130 enrolled 9 charts

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT00047281 2017-07-11

Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma

CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00047294 2017-07-11

Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

CNSSarcoma

Glioblastoma, Glioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00582660 2017-06-15

UAB0040

40 enrolled 7 charts